Day: February 21, 2024

SAN DIEGO, Feb. 21, 2024 (GLOBE NEWSWIRE) — Turnstone Biologics Corp. (“Turnstone” or the “Company”) (Nasdaq: TSBX), a clinical-stage biotechnology company developing a differentiated approach to treat and cure patients with solid tumors by pioneering selected tumor-infiltrating lymphocyte (Selected TIL) therapy, today announced that members of its senior management team will participate in the following investor conferences:TD Cowen 44th Annual Global Health Care Conference     Type:       Presentation and one-on-one investor meetingsSpeaker:   Sammy Farah, M.B.A., Ph.D., President and Chief Executive OfficerDate:   Wednesday, March 6, 2024Presentation Time:   2:10pm ET / 11:10am PTLocation:   Boston, MA     Leerink Partners Global Biopharma Conference 2024     Type:Date:Location:   One-on-one...

Initiative builds on GSMA Open Gateway framework, ensuring international interoperability Amsterdam and Tashkent, 21 February 2024: VEON Ltd. (NASDAQ: VEON, Euronext Amsterdam: VEON), a global digital operator that provides converged connectivity and online services, today announced the launch of the Geolocation Gateway with the first implementation already in place in Uzbekistan.  Building on the global GSMA Open Gateway framework for universal, open APIs (Application Programmable Interfaces) for enterprise developers, the Geolocation Gateway will enable a wide range of use cases, from proximity-based commercial services to reducing fraud in financial services, as well as supporting location-based emergency response.  The Geolocation Gateway, developed by VEON in partnership with Nokia and Infobip, allows applications to determine the...

Boston, Feb. 21, 2024 (GLOBE NEWSWIRE) — Amwell® (NYSE: AMWL), a leader in hybrid care enablement, announced that company executives will participate in the TD Cowen Health Care Conference on Tuesday, March 5 in Boston.  Ido Schoenberg, M.D., Amwell chairman and co-CEO, and Robert Shepardson, Amwell CFO, will participate in a fireside chat at 10:30 a.m. ET, along with one-on-one meetings throughout the day.   An audio webcast of the fireside chat will be available at investors.amwell.com.  About Amwell   Amwell is a leading hybrid care, delivery enablement platform in the United States and globally, connecting and enabling providers, payers, patients, and innovators to deliver greater access to more affordable, higher quality care. Amwell believes that hybrid care delivery will transform healthcare. We offer a single, comprehensive...

In 2023, 5% of all digital transactions originating from Canada were suspected to be fraudulent; 60% of Canadians said they were recently targeted with fraud Key Findings:39% growth in the rate of suspected digital fraud attempts year-over-year (YoY) for transactions originating from Canada in 2023. 60% of Canadians surveyed said they were recently targeted with fraud, of which 10% fell victim. 93% said having confidence their personal data will not be compromised is important when choosing who to transact with online. 42% said they abandon their online shopping carts due to fraud and/or security concerns. 8.4% of e-commerce transactions in 2023 were targeted by suspected fraud attempts originating from Canada. 202% increase in the volume of suspected digital fraud attempts from Canada between 2019-2023. 258% increase in the rate of...

MELBOURNE, Australia, Feb. 21, 2024 (GLOBE NEWSWIRE) — Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company is pleased to advise our Research & Development Manager, Joanne Casey, PhD will be presenting at the Australian Biologics Festival 2024 on Wednesday, 21st February in Melbourne, Australia. A copy of the presentation slide deck is available on the Company’s website. https://www.immuron.com.au/corporate-presentations/ Authorised for release by the Board of Immuron Limited.COMPANY CONTACT:Steven LydeamoreChief Executive OfficerPh: +61 (0)3 9824 5254info@immuron.com            About ImmuronImmuron Limited (ASX: IMC, NASDAQ: IMRN), is an Australian biopharmaceutical company focused on developing and commercialising orally delivered targeted polyclonal antibodies...

Creates a centralised, standardized Pan-European valuation dataset with insights into the factors driving commercial property valuations LONDON, Feb. 21, 2024 (GLOBE NEWSWIRE) — Altus Group Limited (ʺAltus Group” or the “Company”) (TSX: AIF), a leading provider of asset and fund intelligence for commercial real estate (“CRE”), announced today that it has enhanced its European valuation offer with a new Pan-European dataset to compare and analyse commercial property valuation performance. A one of its kind for the European market, the Pan-European valuation dataset brings together valuation data from across the region to provide a new level of insight on “how” and “why” property values are changing. In developing the dataset, Altus Group has brought together its market leading technology, its expertise in valuations, data science...

SINGAPORE, Feb. 21, 2024 (GLOBE NEWSWIRE) — Sound Group Inc. (“Sound Group” or the “Company”) (NASDAQ: SOGP), a global audio-centric social and entertainment company, announced today that it has launched new AI-powered applications for the international market. The Company expects to further develop and enrich its suite of AI products by actively integrating AIGC technologies. Constantly engaged in in-depth research and exploration of cutting-edge technologies such as AIGC, Sound Group leverages its strengths and expertise in product development and operations to optimize its AI technologies. The Company has achieved numerous breakthroughs across various technological niches including Automatic Speech Recognition (ASR), Text-to-Speech (TTS), AI voice, and Large Language Models (LLM) – establishing a solid technical foundation for...